profile_id,first_name,last_name,sub_title,profile_picture,background_image,profile_type,entity_urn,object_urn,birth_date,summary,location,premium,influencer,treasury_media,languages,industry,education,patents,awards,certifications,organizations,projects,publications,courses,test_scores,position_groups,volunteer_experiences,skills,network_info,related_profiles,contact_info
leonard-kruimer-82787167,Leonard,Kruimer,Board Member at Oncolytics Biotech Inc.,https://media.licdn.com/dms/image/C5603AQE3xjQ7AJ7Q5A/profile-displayphoto-shrink_800_800/0/1534773761879?e=1697673600&v=beta&t=EMsllrl1vrx7qsABwkUeg4xRhJjt95fsFiIHsLoLMmA,,personal,ACoAAA4wEl8Btv0P94vCYkg_7w-_KHVVfyYW6fE,238031455,,"Results oriented executive with 30 years progressive experience in biotech, industry and consulting, including extensive experience in project management, finance and general management. Established track record in creating and implementing programs and long term business strategies to boost company growth","{'country': 'Netherlands', 'short': 'Amsterdam, North Holland', 'city': 'Amsterdam', 'state': 'North Holland', 'default': 'Amsterdam, North Holland, Netherlands'}",False,False,[],"{'primary_locale': {'country': 'US', 'language': 'en'}, 'supported_locales': [{'country': 'US', 'language': 'en'}], 'profile_languages': [{'name': 'Dutch', 'proficiency': 'NATIVE_OR_BILINGUAL'}, {'name': 'English', 'proficiency': 'NATIVE_OR_BILINGUAL'}]}",Biotechnology,"[{'date': {'start': {'month': None, 'day': None, 'year': 1982}, 'end': {'month': None, 'day': None, 'year': 1984}}, 'school': {'name': 'Harvard Business School', 'logo': 'https://media.licdn.com/dms/image/C4D0BAQF_DkXTlZVo1w/company-logo_400_400/0/1639781479002?e=1700697600&v=beta&t=pqPqxMllBVamtWB62PNgn-G61A9Bg75eLZaAfYaxrwc', 'url': 'https://www.linkedin.com/school/harvard-business-school/'}, 'degree_name': 'Master of Business Administration (M.B.A.)', 'field_of_study': 'General Management'}, {'date': {'start': {'month': None, 'day': None, 'year': 1976}, 'end': {'month': None, 'day': None, 'year': 1980}}, 'school': {'name': 'Isenberg School of Management, UMass Amherst', 'logo': 'https://media.licdn.com/dms/image/D4E0BAQHdnU7z8zIacg/company-logo_400_400/0/1682705696636?e=1700697600&v=beta&t=BYbs9AnjEdF5BE49DHRvseRVvCggqAmVRHpUH3aESkA', 'url': 'https://www.linkedin.com/school/isenberg-school-of-management-umass-amherst/'}, 'degree_name': 'Bachelor of Business Administration (BBA)', 'field_of_study': 'Accounting and Finance'}, {'date': {'start': {'month': None, 'day': None, 'year': 1970}, 'end': {'month': None, 'day': None, 'year': 1976}}, 'school': {'name': 'Peter Stuyvesant College, Curacao, Neth Antilles', 'logo': None, 'url': None}, 'degree_name': 'High School', 'field_of_study': 'VWO Atheneum'}, {'date': {'start': {'month': None, 'day': None, 'year': 1983}, 'end': {'month': None, 'day': None, 'year': None}}, 'school': {'name': 'University of the State of New York', 'logo': None, 'url': None}, 'degree_name': 'Certified Public Accountant (CPA)', 'field_of_study': None}]",[],[],"[{'name': 'Certified Public Accountant , New York State', 'date': {'start': {'month': None, 'day': None, 'year': None}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': 'AICPA', 'url': None, 'license_number': None, 'display_source': None, 'company': {'id': None, 'name': 'AICPA', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQFV98UAyjaH7g/company-logo_400_400/0/1668198003479?e=1700697600&v=beta&t=OLLNB-SZYqur3bG0wiXdVvUNRwh5qZsid-G02y42jaI', 'url': None}}]",[],[],[],[],[],"[{'company': {'id': None, 'name': 'AI Global Investments (Netherlands) PCC Limited', 'logo': None, 'url': None, 'employees': {'start': None, 'end': None}}, 'date': {'start': {'month': 4, 'day': None, 'year': 2020}, 'end': {'month': None, 'day': None, 'year': None}}, 'profile_positions': [{'location': 'Amsterdam, North Holland, Netherlands', 'date': {'start': {'month': 4, 'day': None, 'year': 2020}, 'end': {'month': None, 'day': None, 'year': None}}, 'company': 'AI Global Investments (Netherlands) PCC Limited', 'description': None, 'title': 'Director', 'employment_type': None}]}, {'company': {'id': 1328604, 'name': 'Oncolytics Biotech Inc.', 'logo': 'https://media.licdn.com/dms/image/C560BAQHuBdkNK4-_eg/company-logo_400_400/0/1519902504427?e=1700697600&v=beta&t=skRsZiUOqfU6XoZQ_wzl_xdD9BIlmTFbaHExCOPTRu8', 'url': 'https://www.linkedin.com/company/oncolytics-biotech-inc./', 'employees': {'start': 11, 'end': 50}}, 'date': {'start': {'month': 9, 'day': None, 'year': 2019}, 'end': {'month': None, 'day': None, 'year': None}}, 'profile_positions': [{'location': 'Calgary, Alberta, Canada', 'date': {'start': {'month': 9, 'day': None, 'year': 2019}, 'end': {'month': None, 'day': None, 'year': None}}, 'company': 'Oncolytics Biotech Inc.', 'description': 'Member of the Audit Committee\nMember of Governance Committee', 'title': 'Board Member', 'employment_type': None}]}, {'company': {'id': 53825499, 'name': 'Zealand Pharma A/S ', 'logo': None, 'url': 'https://www.linkedin.com/company/zealand-pharma-a-s-adr/', 'employees': {'start': 11, 'end': 50}}, 'date': {'start': {'month': 4, 'day': None, 'year': 2019}, 'end': {'month': None, 'day': None, 'year': None}}, 'profile_positions': [{'location': 'Copenhagen, Capital Region, Denmark', 'date': {'start': {'month': 4, 'day': None, 'year': 2019}, 'end': {'month': None, 'day': None, 'year': None}}, 'company': 'Zealand Pharma A/S / ADR', 'description': 'Chairman of the Audit Committee', 'title': 'Member Of The Supervisory Board', 'employment_type': None}]}, {'company': {'id': 48512, 'name': 'BioInvent International AB', 'logo': 'https://media.licdn.com/dms/image/C560BAQHn_JNGk20HvQ/company-logo_400_400/0/1519857003221?e=1700697600&v=beta&t=OVbt2EDOV-SMKA-TvPs2C6ZH_x0-8-f534e1Yme1Ens', 'url': 'https://www.linkedin.com/company/bioinvent-international-ab/', 'employees': {'start': 51, 'end': 200}}, 'date': {'start': {'month': 4, 'day': None, 'year': 2018}, 'end': {'month': None, 'day': None, 'year': None}}, 'profile_positions': [{'location': 'Lund, Sweden', 'date': {'start': {'month': 4, 'day': None, 'year': 2018}, 'end': {'month': None, 'day': None, 'year': None}}, 'company': 'BioInvent International AB', 'description': 'Non executive chairman  of Swedish NASDAQ OMX listed biotech company.', 'title': 'Chairman Of The Supervisory Board', 'employment_type': None}]}, {'company': {'id': None, 'name': 'Kruimer Interim Management', 'logo': None, 'url': None, 'employees': {'start': None, 'end': None}}, 'date': {'start': {'month': 5, 'day': None, 'year': 2016}, 'end': {'month': None, 'day': None, 'year': None}}, 'profile_positions': [{'location': None, 'date': {'start': {'month': 5, 'day': None, 'year': 2016}, 'end': {'month': None, 'day': None, 'year': None}}, 'company': 'Kruimer Interim Management', 'description': 'Provide managent advisory and interim management services to entrepreneurial, fast growing companies, mainly in pharma, biotech and medtech.  Invest selectively in high potentials.', 'title': 'Director', 'employment_type': None}]}, {'company': {'id': 222765, 'name': 'SkylineDx B.V.', 'logo': 'https://media.licdn.com/dms/image/C4D0BAQEk9w56_d9voQ/company-logo_400_400/0/1544774826920?e=1700697600&v=beta&t=YjpOblgxjNZ2JbmDPmaV06xevAF1zTZ40EYJVp1bGX0', 'url': 'https://www.linkedin.com/company/skylinedx-bv/', 'employees': {'start': 51, 'end': 200}}, 'date': {'start': {'month': 8, 'day': None, 'year': 2015}, 'end': {'month': 11, 'day': None, 'year': 2016}}, 'profile_positions': [{'location': 'Rotterdam, The Netherlands', 'date': {'start': {'month': 8, 'day': None, 'year': 2015}, 'end': {'month': 11, 'day': None, 'year': 2016}}, 'company': 'SkylineDx BV', 'description': 'Privately held genetic diagnostics company is launching its forst product in US and Europe. Responsible for corporate development, bringing sysytems up to high professional standards. Responsible for all finance, reporting and planning, tax, legal and compliance. Focus on developing the organization and formulate and implement strategy going forward.', 'title': 'Chief Financial Officer', 'employment_type': None}]}, {'company': {'id': 220320, 'name': 'to-BBB', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQH1Bmcvz8lbWQ/company-logo_400_400/0/1519900096404?e=1700697600&v=beta&t=BnhfLRGF6PlzLnNfgL_at6P2tlwEWQ7X4vvfxqd7WoM', 'url': 'https://www.linkedin.com/company/to-bbb/', 'employees': {'start': 11, 'end': 50}}, 'date': {'start': {'month': 1, 'day': None, 'year': 2014}, 'end': {'month': 2, 'day': None, 'year': 2015}}, 'profile_positions': [{'location': 'Leiden Bioscience Park', 'date': {'start': {'month': 1, 'day': None, 'year': 2014}, 'end': {'month': 2, 'day': None, 'year': 2015}}, 'company': 'BBB Therapeutics', 'description': 'Privately held biotech developed new treatments for devastating brain diseases. Mandated to focus R&D efforts and prepare the company for public offering. Restructured management board and recruited new management team. Restructured  organization and downsized research programs.  Completed €10 mill financing C round in May 2014. Existing investors would not finance further clinical development, leading to liquidation of the company in 2015.', 'title': 'acting CEO, CFO', 'employment_type': None}]}, {'company': {'id': None, 'name': 'ProFibrix BV', 'logo': None, 'url': None, 'employees': {'start': None, 'end': None}}, 'date': {'start': {'month': 1, 'day': None, 'year': 2011}, 'end': {'month': 8, 'day': None, 'year': 2013}}, 'profile_positions': [{'location': 'Leiden, The Netherlands and Seattle, Washington, USA', 'date': {'start': {'month': 1, 'day': None, 'year': 2011}, 'end': {'month': 8, 'day': None, 'year': 2013}}, 'company': 'ProFibrix BV', 'description': 'Independent non exec Chairman of privately held haematology company. Also chairman of audit committee.  Company was acquired in 2013 by The Medicines Company (Nasdaq MDCO) for over €400 mill.', 'title': 'Chairman  Supervisory Board', 'employment_type': None}]}, {'company': {'id': 15417, 'name': 'Crucell', 'logo': 'https://media.licdn.com/dms/image/C560BAQG4IkT-TRWuLQ/company-logo_400_400/0/1519855939934?e=1700697600&v=beta&t=5Qb9elfQBLNXJpr4bGzaN05u7I3k74usdBR2EZsbPNM', 'url': 'https://www.linkedin.com/company/crucell/', 'employees': {'start': 1001, 'end': 5000}}, 'date': {'start': {'month': 6, 'day': None, 'year': 1998}, 'end': {'month': 1, 'day': None, 'year': 2012}}, 'profile_positions': [{'location': 'Leiden, The Netherlands and Bern, Switserland', 'date': {'start': {'month': 6, 'day': None, 'year': 1998}, 'end': {'month': 1, 'day': None, 'year': 2012}}, 'company': 'Crucell', 'description': ""Build gene therapy startup into one of the world's largest independent vaccine corporation, headquartered in the Netherlands and Switserland with operating and manufacturing companies in Switserland, Sweden, Spain and South Korea. Subsidiaries and joint ventures in the United States and Taiwan. 2010 revenues exceeded $500 million and profitable. Led €144 mill Nasdaq and NYSE-Euronext Amsterdam IPO in October 2000, listed on SWX Zurich in 2006 concurrent with Berna Biotech AG acquisition. Acquired SBL Vaccines AB in Sweden in 2006. JNJ launched a successful takeover bid in 2010, resulting in a $2.7 billion acquisition in March 2011. Approximately 1500 employees worldwide. \nRaised over $800 million in multiple public financing rounds. Responsible for strategy and target setting, implementation and evaluation. Finace responsibilities included risk management, Sarbanes Oxley compliance. Executing and integrating acquisitions and cost management. Chief compliance Officer. Responsible for IR and PR."", 'title': 'Managing Board Member and CFO.', 'employment_type': None}]}, {'company': {'id': None, 'name': 'Boskalis NV', 'logo': None, 'url': None, 'employees': {'start': None, 'end': None}}, 'date': {'start': {'month': 8, 'day': None, 'year': 1995}, 'end': {'month': 12, 'day': None, 'year': 1996}}, 'profile_positions': [{'location': 'Rotterdam Area, Netherlands', 'date': {'start': {'month': 8, 'day': None, 'year': 1995}, 'end': {'month': 12, 'day': None, 'year': 1996}}, 'company': 'Boskalis NV', 'description': ""Strategy review of world's leading contractor of harbours and waterways; took on corporate financial responsibilities as an interim position, reporting to CEO."", 'title': 'Corporate Treasurer', 'employment_type': None}]}]",[],"['Improving efficiency and operational effectiveness', 'IPOs and public and private fund raising in US and Europe', 'Finance and control', 'Long range planning and business strategy development', 'IR and communication', 'Extensive international network', 'Pharmaceutical Industry', 'Management', 'Business Strategy', 'Lifesciences']",,,
